Edesa Biotech, Inc.
EDSA
$7.69
$0.699.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.25% | 29.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.21% | 29.76% | |||
| Operating Income | 5.21% | -29.76% | |||
| Income Before Tax | -0.87% | -27.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.87% | -27.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.87% | -27.37% | |||
| EBIT | 5.21% | -29.76% | |||
| EBITDA | 5.26% | -30.16% | |||
| EPS Basic | 10.76% | -26.82% | |||
| Normalized Basic EPS | 16.01% | -27.50% | |||
| EPS Diluted | 10.76% | -26.82% | |||
| Normalized Diluted EPS | 16.01% | -27.50% | |||
| Average Basic Shares Outstanding | 13.01% | 0.46% | |||
| Average Diluted Shares Outstanding | 13.01% | 0.46% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||